全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS Biology  2015 

Chloe’s Law: A Powerful Legislative Movement Challenging a Core Ethical Norm of Genetic Testing

DOI: 10.1371/journal.pbio.1002219

Full-Text   Cite this paper   Add to My Lib

Abstract:

Since the early 1970s, the ethical norm governing counselors involved in testing and screening for genetic conditions related to reproduction has been strict neutrality. Counseling about reproductive genetics was to be patient centered but nondirective. Many advocates for people with Down syndrome believe that high abortion rates following a diagnosis of this condition show an unfounded bias against those with Down syndrome. These advocates have succeeded in enacting federal and state legislation that requires women who receive a prenatal diagnosis of Down syndrome to receive positive information about the condition, thereby ending the nominal goal of value-neutral counseling and setting the stage for further normative shifts in clinical reproductive genetics as counseling expands because of cell-free testing.

References

[1]  Down Syndrome Prenatal Education Act (“Chloe’s Law”). Pub. L. 2450, No. 130, Cl. 35. (Jul 18, 2014). .
[2]  Chloe’s Law Now Act 130 of 2014. 2014 July 22. In: Pennsylvania News & Buzz [Internet]. .
[3]  Maternal Age and Risk for Down Syndrome. 2014 April 9. In: NIH [Internet]. .
[4]  Stern AM. Telling Genes: The Story of Genetic Counseling in America. Baltimore: Johns Hopkins University Press; 2012.
[5]  Caplan AL, LeRoy BS, Bartels DM, eds. Prescribing Our Future: Ethical Challenges in Genetic Counseling. New York: Aldine Transaction; 1993.
[6]  LeRoy BS. Nondirectiveness: Encyclopedia of the Life Sciences. Published Online: 15 SEP 2006. doi: 10.1002/9780470015902.a0005894.
[7]  Morris JK, Springett A. The National Down Syndrome Cytogenetic Register for England and Wales: 2012 Annual Report. Jan 2014. .
[8]  Skotko BG. With new prenatal testing, will babies with Down syndrome slowly disappear? Arch Dis Child. 2009; 94: 823–826. doi: 10.1136/adc.2009.166017. pmid:19531527
[9]  Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A. Impact of a new national screening policy for Down’s syndrome in Denmark: population based cohort study. BMJ. 2009; 338: 449–52. doi: 10.1136/bmj.a2547
[10]  Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, et al. Cell-free DNA Analysis for Noninvasive Examination of Trisomy. N Engl J Med. 2015; 372:1589–1597. doi: 10.1056/NEJMoa1407349. pmid:25830321

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133